Hysingla ER
These highlights do not include all the information needed to use HYSINGLA ER safely and effectively. See full prescribing information for HYSINGLA ER. HYSINGLA ER (hydrocodone bitartrate) extended-release tablets, for oral use, CIIInitial U.S. Approval: 1943
b7d23ac2-e776-9f62-3290-c64c2d6eb353
HUMAN PRESCRIPTION DRUG LABEL
Dec 18, 2023
Purdue Pharma LP
DUNS: 932323652
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (11)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (12)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (13)
hydrocodone bitartrate
Product Details
FDA regulatory identification and product classification information